CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (5)
2024
-
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
The Lancet Haematology, Vol. 11, Núm. 2, pp. e147-e159
2020
-
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Frontiers in Immunology, Vol. 11
-
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
The Lancet Haematology, Vol. 7, Núm. 2, pp. e157-e167
2019
-
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster after Autologous Stem Cell Transplantation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 322, Núm. 2, pp. 123-133
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380